Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to determine the efficacy of Sensi Peel®, Rejuvenating Serum, and the C&E Strength Max skin care products in subjects who undergo full facial rejuvenation, with a botulinum neurotoxin A and/or hyaluronic acid filler, in improving the appearance of the skin, patient satisfaction with aesthetic appearance, and the projected first impressions.

The secondary objective of this study is to examine patient satisfaction with the continuous use of Sensi Peel®, Rejuvenating Serum, and the C&E Strength Max products.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Facial Rejuvenation With Neurotoxins and/or Hyaluronic Acid Fillers
  • Facies

NCT number NCT02726451
Study type Interventional
Source DeNova Research
Contact
Status Completed
Phase N/A
Start date March 2016
Completion date December 11, 2016